Skip to main content
Erschienen in: Tumor Biology 7/2014

01.07.2014 | Research Article

Aberrant DNA methylation of integrin α4 in human breast cancer

verfasst von: Sung-Im Do, Eunkyung Ko, So Young Kang, Jeong Eon Lee, Seok Jin Nam, Eun Yoon Cho, Duk-Hwan Kim

Erschienen in: Tumor Biology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Integrins are cell surface receptors that mediate cell–cell/extracellular interactions and have shown an association with metastasis or transformation in several cancers. However, the correlation between the clinicopathological status of breast cancer and the altered integrin α4 status is not clear. In this study, we investigated DNA methylation of integrin α4 in breast cancer. We retrieved 351 cases of surgically resected breast cancer (290 invasive carcinoma and 61 intraductal carcinoma). Methylation-specific polymerase chain reaction was performed to determine integrin α4 methylation status. Integrin α4 methylation was frequently observed in breast cancer specimens (145/351 cases, 41.3 %). In addition, DNA methylation of integrin α4 showed statistical correlation with HER2 positivity and higher histologic grade (p = 0.001, 0.008 in ductal carcinoma in situ and 0.003 in invasive ductal carcinoma). However, other clinicopathological data such as estrogen receptor, progesterone receptor, metastasis, and TNM status showed no statistical correlation. Moreover, we found that the downregulated expression of integrin α4 in a heavily methylated breast cancer cell line (ZR-75) was restored by treatment with 5-aza-2'deoxycytidine, a DNA methyltransferase inhibitor, implying transcriptional silencing by DNA methylation. We observed that integrin α4 methylation is associated with the histologic grade of tumors and lymph node metastasis. Also, this data supports a previous study that suggested integrin α4 and HER2 are involved in the same signaling pathway. DNA methylation of integrin α4 may be a poor prognostic factor which affects undifferentiated histologic change of breast cancer.
Literatur
1.
Zurück zum Zitat Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173–206.CrossRefPubMed Giancotti FG, Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu Rev Cell Dev Biol. 2003;19:173–206.CrossRefPubMed
2.
Zurück zum Zitat van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305(3):285–98.CrossRefPubMed van der Flier A, Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 2001;305(3):285–98.CrossRefPubMed
3.
Zurück zum Zitat Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11–25.CrossRefPubMed Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11–25.CrossRefPubMed
4.
Zurück zum Zitat Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol. 2002;4(4):E83–90.CrossRefPubMed Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol. 2002;4(4):E83–90.CrossRefPubMed
5.
Zurück zum Zitat Aplin AE, Howe AK, Juliano RL. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol. 1999;11(6):737–44.CrossRefPubMed Aplin AE, Howe AK, Juliano RL. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol. 1999;11(6):737–44.CrossRefPubMed
6.
Zurück zum Zitat Chan BM, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. Cell. 1992;68(6):1051–60.CrossRefPubMed Chan BM, Kassner PD, Schiro JA, Byers HR, Kupper TS, Hemler ME. Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. Cell. 1992;68(6):1051–60.CrossRefPubMed
7.
Zurück zum Zitat Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol. 1994;152(7):3282–93.PubMed Hamann A, Andrew DP, Jablonski-Westrich D, Holzmann B, Butcher EC. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol. 1994;152(7):3282–93.PubMed
8.
Zurück zum Zitat Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology. 2000;119(1):109–18.CrossRefPubMed Michetti M, Kelly CP, Kraehenbuhl JP, Bouzourene H, Michetti P. Gastric mucosal alpha(4)beta(7)-integrin-positive CD4 T lymphocytes and immune protection against helicobacter infection in mice. Gastroenterology. 2000;119(1):109–18.CrossRefPubMed
9.
Zurück zum Zitat Holzmann B, Gosslar U, Bittner M. alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immunol. 1998;231:125–41.PubMed Holzmann B, Gosslar U, Bittner M. alpha 4 integrins and tumor metastasis. Curr Top Microbiol Immunol. 1998;231:125–41.PubMed
10.
Zurück zum Zitat Rincon J, Prieto J, Patarroyo M. Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells. Int J Cancer. 1992;51(3):452–8.CrossRefPubMed Rincon J, Prieto J, Patarroyo M. Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells. Int J Cancer. 1992;51(3):452–8.CrossRefPubMed
11.
Zurück zum Zitat Gosslar U, Jonas P, Luz A, Lifka A, Naor D, Hamann A, et al. Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis. Proc Natl Acad Sci U S A. 1996;93(10):4821–6.PubMedCentralCrossRefPubMed Gosslar U, Jonas P, Luz A, Lifka A, Naor D, Hamann A, et al. Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis. Proc Natl Acad Sci U S A. 1996;93(10):4821–6.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Qian F, Vaux DL, Weissman IL. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell. 1994;77(3):335–47.CrossRefPubMed Qian F, Vaux DL, Weissman IL. Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation. Cell. 1994;77(3):335–47.CrossRefPubMed
13.
Zurück zum Zitat Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 1996;56(4):722–7.PubMed Herman JG, Jen J, Merlo A, Baylin SB. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res. 1996;56(4):722–7.PubMed
14.
Zurück zum Zitat Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998;95(12):6870–5.PubMedCentralCrossRefPubMed Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A. 1998;95(12):6870–5.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, et al. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene. 1999;18(51):7280–6.CrossRefPubMed Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, et al. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene. 1999;18(51):7280–6.CrossRefPubMed
16.
Zurück zum Zitat Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, et al. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer. 2000;87(2):236–40.CrossRefPubMed Song SH, Jong HS, Choi HH, Kang SH, Ryu MH, Kim NK, et al. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma. Int J Cancer. 2000;87(2):236–40.CrossRefPubMed
17.
Zurück zum Zitat Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57(11):2229–37.PubMed Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57(11):2229–37.PubMed
18.
Zurück zum Zitat Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168–74.CrossRefPubMed Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16(4):168–74.CrossRefPubMed
19.
Zurück zum Zitat Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y. Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta. 2004;349(1–2):173–9.CrossRefPubMed Gao Y, Guan M, Su B, Liu W, Xu M, Lu Y. Hypermethylation of the RASSF1A gene in gliomas. Clin Chim Acta. 2004;349(1–2):173–9.CrossRefPubMed
20.
Zurück zum Zitat Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer. 2004;112(5):754–9.CrossRefPubMed Goel A, Arnold CN, Tassone P, Chang DK, Niedzwiecki D, Dowell JM, et al. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers. Int J Cancer. 2004;112(5):754–9.CrossRefPubMed
21.
Zurück zum Zitat Lindsey JC, Lusher ME, Strathdee G, Brown R, Gilbertson RJ, Bailey S, et al. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. Int J Cancer. 2006;118(2):346–52.CrossRefPubMed Lindsey JC, Lusher ME, Strathdee G, Brown R, Gilbertson RJ, Bailey S, et al. Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. Int J Cancer. 2006;118(2):346–52.CrossRefPubMed
22.
Zurück zum Zitat Maruyama R, Shoji F, Okamoto T, Miyamoto T, Miyake T, Nakamura T, et al. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution. J Thorac Cardiovasc Surg. 2004;127(6):1587–92.CrossRefPubMed Maruyama R, Shoji F, Okamoto T, Miyamoto T, Miyake T, Nakamura T, et al. Prognostic value of visceral pleural invasion in resected non-small cell lung cancer diagnosed by using a jet stream of saline solution. J Thorac Cardiovasc Surg. 2004;127(6):1587–92.CrossRefPubMed
23.
Zurück zum Zitat Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Cancer. 2004;100(7):1472–7.CrossRefPubMed Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma. Cancer. 2004;100(7):1472–7.CrossRefPubMed
24.
Zurück zum Zitat Park J, Song SH, Kim TY, Choi MC, Jong HS, Lee JW, et al. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene. 2004;23(19):3474–80.CrossRefPubMed Park J, Song SH, Kim TY, Choi MC, Jong HS, Lee JW, et al. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells. Oncogene. 2004;23(19):3474–80.CrossRefPubMed
25.
Zurück zum Zitat Uhm KO, Lee JO, Lee YM, Lee ES, Kim HS, Park SH. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma. J Cancer Res Clin Oncol. 2010;136(2):187–94.CrossRefPubMed Uhm KO, Lee JO, Lee YM, Lee ES, Kim HS, Park SH. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma. J Cancer Res Clin Oncol. 2010;136(2):187–94.CrossRefPubMed
27.
Zurück zum Zitat Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev. 2010;29(1):223–37.CrossRefPubMed Rathinam R, Alahari SK. Important role of integrins in the cancer biology. Cancer Metastasis Rev. 2010;29(1):223–37.CrossRefPubMed
28.
Zurück zum Zitat Yoon SO, Shin S, Lipscomb EA. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res. 2006;66(5):2732–9.CrossRefPubMed Yoon SO, Shin S, Lipscomb EA. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling. Cancer Res. 2006;66(5):2732–9.CrossRefPubMed
Metadaten
Titel
Aberrant DNA methylation of integrin α4 in human breast cancer
verfasst von
Sung-Im Do
Eunkyung Ko
So Young Kang
Jeong Eon Lee
Seok Jin Nam
Eun Yoon Cho
Duk-Hwan Kim
Publikationsdatum
01.07.2014
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 7/2014
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1952-7

Weitere Artikel der Ausgabe 7/2014

Tumor Biology 7/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.